Counterpoint Mutual Funds’s Cerence CRNC Stock Holding History

Counterpoint Mutual Funds’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,011	Closed	-$224K	–	149
2023 Q3	$224K	Buy	+11,011	New	+$277K	0.19%	44

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Counterpoint Mutual Funds's CRNC Position: Q4 2023 in Review

Counterpoint Mutual Funds sold out of Cerence (CRNC) in Q4 2023, closing a stake of 11,011 shares — an estimated $224K sold.

Counterpoint Mutual Funds first reported a position in CRNC in Q3 2023 and held it in 1 quarter. The position peaked at $224K in Q3 2023. 217 funds tracked by Wall St. Rank hold CRNC as of Q4 2023.

Counterpoint Mutual Funds reported no remaining Cerence position as of Q4 2023 after selling out during the quarter.
Counterpoint Mutual Funds sold 11,011 Cerence shares in Q4 2023, an estimated $224K.
Counterpoint Mutual Funds first reported a position in Cerence in Q3 2023 and held it in 1 quarter.
Counterpoint Mutual Funds's Cerence position peaked at $224K in Q3 2023.
217 funds tracked by Wall St. Rank held Cerence as of Q4 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2023, filed 7 Feb 2024.